Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β‐catenin levels
Authors:
Open Access
- 1 September 2009
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (9b) , 3687-3698
Abstract
Endostatin is a well‐characterized endogenous inhibitor of angiogenesis that affects cell proliferation and migration by inhibiting integrin and Wnt‐mediated signalling pathways. Here, we show that endothelial cells treated with native and P125A‐endostatin activate autophagy. Because autophagy can either be protective or induce programmed cell death, experiments were carried out to understand the signalling pathways leading to autophagy in endothelial cells. P125A‐endostatin treatment increased the levels of Beclin 1, a crucial molecule in vesicle nucleation and autophagy. The treatment also reduced the levels of Bcl‐2, Bcl‐xL and β‐catenin; however, progressively increasing amounts of Bcl‐2 and Bcl‐xL were found to be complexed with Beclin 1. Increased β‐catenin and Wnt‐mediated signalling reduced Beclin 1 levels and rescued endothelial cells from endostatin‐induced autophagy. Finally, knocking down Beclin 1 levels by RNA interference decreased autophagy and accelerated caspase activation in endostatin‐treated cells. These studies suggest that endothelial cells may initiate autophagy as a survival response to limit the effects of angiogenesis inhibitors. Thus, interfering with autophagy can potentiate the effects of endostatin by promoting a switch to apoptosis.Keywords
This publication has 42 references indexed in Scilit:
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- Binding of endostatin to human ovarian cancer cells inhibits cell attachmentInternational Journal of Cancer, 2007
- Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cellsBlood, 2007
- Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1The EMBO Journal, 2007
- Angiogenesis: an organizing principle for drug discovery?Nature Reviews Drug Discovery, 2007
- Shutting down Wnt signal–activated cancerNature Genetics, 2004
- Endostatin Associates with Lipid Rafts and Induces Reorganization of the Actin Cytoskeleton via Down-regulation of RhoA ActivityJournal of Biological Chemistry, 2003
- Endostatin is a potential inhibitor of Wnt signalingJournal of Cell Biology, 2002
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997